Researchers at the Salk Institute have published Superb-seq, a method that examines individual cells to find intended and unintended DNA changes from CRISPR-Cas9 gene editing and measure how those changes affect gene activity.
The approach combines CRISPR editing, transcription using T7, and RNA sequencing of individual cells. It connects DNA changes with the pattern of gene activity in each cell. This link matters because conventional methods can identify a guide RNA or measure gene activity without showing which edits actually happened in a cell.
In tests involving more than 34,000 cells from three cell lines, the team examined 10,000 leukemia cells edited using seven guide RNAs. They found 43 edit sites, 36 of them outside the intended targets, and 5,761 cells had edits. Researchers also linked 19 unintended edits to changes in gene activity.
Those effects varied by cell type. The findings show that unintended edits can make CRISPR experiments harder to interpret. However, the work was done in laboratory cell lines and does not establish risks to patients.
The researchers say the method could help scientists assess CRISPR experiments and investigate the safety of potential gene-editing therapies.